New hope for type 1 diabetes: can two popular drugs help control blood sugar without weight gain?
NCT ID NCT06762314
First seen Mar 14, 2026 · Last updated May 01, 2026 · Updated 8 times
Summary
This study tests whether adding empagliflozin or semaglutide to insulin helps overweight or obese adults with type 1 diabetes achieve better blood sugar control. About 105 participants will take one of the two drugs or a placebo for 3 months. The goal is to lower HbA1c levels safely without causing dangerous low blood sugar or weight gain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Tanta Unuversity
RECRUITINGTanta, 31527, Egypt
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.